BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9377919)

  • 1. Characterization of amiodarone pneumonitis as related to inflammatory cells and surfactant apoprotein.
    Nagata N; Suematsu R; Yoshii C; Miyazaki H; Sueishi K; Kido M
    Chest; 1997 Oct; 112(4):1068-74. PubMed ID: 9377919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A characterization of amiodarone-induced pulmonary toxicity in F344 rats and identification of surfactant protein-D as a potential biomarker for the development of the toxicity.
    Taylor MD; Van Dyke K; Bowman LL; Miles PR; Hubbs AF; Mason RJ; Shannon K; Reasor MJ
    Toxicol Appl Pharmacol; 2000 Sep; 167(3):182-90. PubMed ID: 10986009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone-induced pulmonary toxicity in the rat.
    Wilson BD; Jaworski AJ; Donner ME; Lippmann ML
    Lung; 1989; 167(5):301-11. PubMed ID: 2507834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between inflammatory cells in bronchoalveolar lavage fluid and pathologic changes in the lung interstitium.
    Yoshii C; Nagata N; Tao Y; Suematsu R; Nikaido Y; Kido M
    Respiration; 1998; 65(5):386-92. PubMed ID: 9782222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse alveolar damage and acute interstitial pneumonitis: histochemical evaluation with lectins and monoclonal antibodies against surfactant apoprotein and collagen type IV.
    Sugiyama K; Kawai T
    Mod Pathol; 1993 May; 6(3):242-8. PubMed ID: 8346171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amiodarone-induced pneumonitis associated with marked eosinophilia in BALF].
    Sato S; Watanabe K; Ishida T; Yoshikawa M; Kanazawa K; Saito J; Ohtsuka Y; Suzuki H; Maruyama Y; Munakata M
    Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):356-8. PubMed ID: 16536086
    [No Abstract]   [Full Text] [Related]  

  • 7. Altered regulation of surfactant phospholipid and protein A during acute pulmonary inflammation.
    Viviano CJ; Bakewell WE; Dixon D; Dethloff LA; Hook GE
    Biochim Biophys Acta; 1995 Dec; 1259(3):235-44. PubMed ID: 8541330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant apoprotein in nonmalignant pulmonary disorders.
    Singh G; Katyal SL
    Am J Pathol; 1980 Oct; 101(1):51-61. PubMed ID: 7004201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of blood leucocyte depletion on the inflammatory response of the lung to quartz.
    Henderson RF; Harkema JR; Hotchkiss JA; Boehme DS
    Toxicol Appl Pharmacol; 1991 Jun; 109(1):127-36. PubMed ID: 2038743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalation of titanium dioxide (P25) nanoparticles to rats and changes in surfactant protein (SP-D) levels in bronchoalveolar lavage fluid and serum.
    Okada T; Lee BW; Ogami A; Oyabu T; Myojo T
    Nanotoxicology; 2019 Dec; 13(10):1396-1408. PubMed ID: 31512956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats.
    Punithavathi D; Venkatesan N; Babu M
    Br J Pharmacol; 2003 Aug; 139(7):1342-50. PubMed ID: 12890714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone pulmonary toxicity: cytopathology, ultrastructure, and immunocytochemistry.
    Bedrossian CW; Warren CJ; Ohar J; Bhan R
    Ann Diagn Pathol; 1997 Oct; 1(1):47-56. PubMed ID: 9869825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of Stemona tuberosa on lung inflammation in a subacute cigarette smoke-induced mouse model.
    Lee H; Jung KH; Park S; Kil YS; Chung EY; Jang YP; Seo EK; Bae H
    BMC Complement Altern Med; 2014 Dec; 14():513. PubMed ID: 25528348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical and morphological evidence for the origin of N-nitrosomethylurea-induced and naturally occurring primary lung tumors in F344/NCr rats.
    Ohshima M; Ward JM; Singh G; Katyal SL
    Cancer Res; 1985 Jun; 45(6):2785-92. PubMed ID: 3886137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary alveolar proteinosis. Staining for surfactant apoprotein in alveolar proteinosis and in conditions simulating it.
    Singh G; Katyal SL; Bedrossian CW; Rogers RM
    Chest; 1983 Jan; 83(1):82-6. PubMed ID: 6336692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of EGF receptor and erbB-2 during endotoxin-induced alveolar type II cell proliferation in the rat lung.
    Tesfaigzi J; Johnson NF; Lechner JF
    Int J Exp Pathol; 1996 Aug; 77(4):143-54. PubMed ID: 8943732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amount of Pneumocystis carinii and degree of acute lung inflammation in HIV-associated P carinii pneumonia.
    Vestbo J; Nielsen TL; Junge J; Lundgren JD
    Chest; 1993 Jul; 104(1):109-13. PubMed ID: 8100757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone-induced pulmonary toxicity in Fischer rats: release of tumor necrosis factor alpha and transforming growth factor beta by pulmonary alveolar macrophages.
    Reinhart PG; Gairola CG
    J Toxicol Environ Health; 1997 Nov; 52(4):353-65. PubMed ID: 9354180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary surfactant activity is impaired in lung transplant recipients.
    Hohlfeld JM; Tiryaki E; Hamm H; Hoymann HG; Krug N; Haverich A; Fabel H
    Am J Respir Crit Care Med; 1998 Sep; 158(3):706-12. PubMed ID: 9730994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of surfactant lipids by neutrophils and macrophages isolated from the acutely inflamed lung.
    Quintero OA; Wright JR
    Am J Physiol Lung Cell Mol Physiol; 2002 Feb; 282(2):L330-9. PubMed ID: 11792638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.